lu 135252 has been researched along with Heart Failure in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (11.54) | 18.2507 |
2000's | 23 (88.46) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Epstein, BJ | 1 |
Dietz, R; Langenickel, T; Lüscher, T; Monti, J; Notter, T; Pagel, I; Philipp, S; Ruschitzka, F; Willenbrock, R | 1 |
Boujedaini, H; Henry, JP; Mulder, P; Münter, K; Renet, S; Richard, V; Thuillez, C | 1 |
Bauersachs, J; Ertl, G; Fraccarollo, D; Schäfer, A | 1 |
Goldenthal, MJ; Marín-García, J; Moe, GW | 1 |
Dietz, R; Enseleit, F; Hürlimann, D; Lüscher, TF; Mitrovic, V; Noll, G; Notter, T; Pacher, R; Philipp, S; Rousson, V; Ruschitzka, F; Schulze, MR; Willenbrock, R | 1 |
Lüscher, TF; Spieker, LE | 1 |
Piuhola, J; Ruskoaho, H; Szokodi, I | 1 |
Austin, PC; Lapointe, N; Lee, DS; Nguyen, QT; Ohlsson, A; Rouleau, JL; Stewart, DJ; Tu, JV | 1 |
Boerrigter, G; Burnett, JC; Cataliotti, A; Chen, HH; Jougasaki, M; Lisy, O; Schirger, JA | 1 |
Berger, R; Bergler-Klein, J; Bojic, A; Pacher, R; Stanek, B | 1 |
Miyauchi, T | 1 |
Backs, J; Bresch, E; Haass, M; Kristen, AV; Lutz, M | 1 |
Daemen, MJ; Dorenkamp, M; Reinecke, A; Simon, R; Unger, T; Xia, QG | 1 |
Albernaz, A; Huntington, K; Moe, G; Monge, JC; Picard, P; Stewart, DJ | 1 |
Bouchart, F; Derumeaux, G; Mulder, P; Münter, K; Richard, V; Thuillez, C | 1 |
Albernaz, A; Kirchengast, M; Moe, GW; Naik, GO; Stewart, DJ | 1 |
Kiowski, W; Lüscher, TF; Mitrovic, V; Muntwyler, J; Noll, G; Pacher, R; Schalcher, C; Schulze, MR; Spieker, LE | 1 |
Bauersachs, J; Ertl, G; Fraccarollo, D; Galuppo, P; Widder, J | 1 |
Cernacek, P; Dupuis, J; Lucas, M; Thorin, E | 1 |
Bauersachs, J; Braun, C; Ertl, G; Fraccarollo, D; Kirchengast, M; Rohmeiss, P; Schilling, L; Widder, J | 1 |
Berger, R; Frey, B; Heher, S; Hülsmann, M; Neunteufl, T; Pacher, R; Stanek, B | 1 |
Lüscher, TF; Noll, G; Ruschitzka, FT; Spieker, LE | 1 |
Dupuis, J; Jasmin, JF; Lucas, M | 1 |
Cheng, TO | 1 |
Bauersachs, J; Ertl, G; Fraccarollo, D; Galuppo, P; Kellner, M | 1 |
4 review(s) available for lu 135252 and Heart Failure
Article | Year |
---|---|
Will endothelin receptor antagonists have a role in heart failure?
Topics: Animals; Bosentan; Cardiovascular Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Humans; Isoxazoles; Oligopeptides; Peptides, Cyclic; Phenylpropionates; Piperidines; Pyridines; Pyrimidines; Sulfonamides; Tetrazoles; Thiophenes; Treatment Outcome | 2003 |
Meta-analysis of the effects of endothelin receptor blockade on survival in experimental heart failure.
Topics: Animals; Atrasentan; Cardiotonic Agents; Endothelin Receptor Antagonists; Heart Failure; Peptides, Cyclic; Phenylpropionates; Pyrimidines; Pyrrolidines; Rats; Risk; Survival Rate | 2003 |
[Endothelin and heart failure].
Topics: Animals; Biomarkers; Clinical Trials as Topic; Drug Design; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Heart Failure; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neovascularization, Pathologic; Peptides, Cyclic; Phenylpropionates; Pyrimidines; Transcription Factors; Vasoconstriction; Ventricular Remodeling | 2004 |
Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Topics: Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Forecasting; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Myocardial Contraction; Peptides, Cyclic; Phenylpropionates; Predictive Value of Tests; Prognosis; Pyrimidines; Sulfonamides; Time Factors; Vascular Resistance; Vasoconstriction; Ventricular Function, Left | 2001 |
4 trial(s) available for lu 135252 and Heart Failure
Article | Year |
---|---|
Treatment with darusentan over 21 days improved cGMP generation in patients with chronic heart failure.
Topics: Atrial Natriuretic Factor; Cardiac Output; Cyclic GMP; Double-Blind Method; Drug Administration Schedule; Endothelin Receptor Antagonists; Heart Failure; Humans; Middle Aged; Natriuretic Peptide, Brain; Phenylpropionates; Pyrimidines; Receptor, Endothelin A; Vasodilator Agents | 2002 |
Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
Topics: Blood Pressure; Catecholamines; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Eruptions; Endothelin Receptor Antagonists; Europe; Female; Follow-Up Studies; Headache; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Hypotension; Male; Middle Aged; Phenylpropionates; Pulmonary Wedge Pressure; Pyrimidines; Receptor, Endothelin A; Shock, Cardiogenic; Treatment Outcome; Vascular Resistance; Ventricular Fibrillation | 2002 |
Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failure.
Topics: Atrial Natriuretic Factor; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin A Receptor Antagonists; Endothelin-1; Female; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Liver Function Tests; Male; Middle Aged; Natriuretic Peptide, Brain; Phenylpropionates; Pyrimidines | 2004 |
Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure.
Topics: Blood Flow Velocity; Brachial Artery; Chronic Disease; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Endothelium, Vascular; Female; Heart Failure; Heart Function Tests; Humans; Linear Models; Male; Middle Aged; Nitroglycerin; Phenylpropionates; Protein Precursors; Pyrimidines; Receptor, Endothelin A; Treatment Outcome; Vasodilation | 2001 |
18 other study(ies) available for lu 135252 and Heart Failure
Article | Year |
---|---|
Efficacy and safety of darusentan: a novel endothelin receptor antagonist.
Topics: Antihypertensive Agents; Endothelin A Receptor Antagonists; Heart Failure; Humans; Hypertension; Phenylpropionates; Pyrimidines; Substrate Specificity | 2008 |
Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Coronary Vessels; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Endothelin Receptor Antagonists; Heart Failure; Hemodynamics; Ligation; Male; Myocardium; Peptidyl-Dipeptidase A; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; Stroke Volume; Survival Rate; Ventricular Function, Left; Ventricular Remodeling; Wakefulness | 2002 |
Angiotensin-converting enzyme inhibition and endothelin antagonism for endothelial dysfunction in heart failure: mono-or combination therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelium, Vascular; Heart Failure; In Vitro Techniques; Indoles; Male; Peptidyl-Dipeptidase A; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; Vasodilation | 2002 |
Selective endothelin receptor blockade reverses mitochondrial dysfunction in canine heart failure.
Topics: Adenosine Triphosphatases; Animals; Cardiac Pacing, Artificial; Carrier Proteins; Citrate (si)-Synthase; Citric Acid Cycle; Disease Models, Animal; Dogs; Endothelin Receptor Antagonists; Heart Failure; Hemodynamics; Membrane Proteins; Mitochondria, Heart; Mitochondrial Proton-Translocating ATPases; Models, Cardiovascular; Multienzyme Complexes; Muscle, Skeletal; Oxidative Phosphorylation; Oxidative Stress; Phenylpropionates; Pyrimidines; Treatment Outcome | 2002 |
Endothelin receptor blockade and exacerbation of heart failure.
Topics: Animals; Bosentan; Chronic Disease; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelins; Heart; Heart Failure; Humans; Myocardial Contraction; Phenylpropionates; Pyrimidines; Rats; Receptor, Endothelin A; Sulfonamides; Vascular Resistance; Water-Electrolyte Balance | 2003 |
Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention.
Topics: Animals; Disease Progression; Dogs; Endothelin A Receptor Antagonists; Endothelin-1; Heart Failure; Hemodynamics; Kidney; Male; Phenylpropionates; Pyrimidines; Renin; Renin-Angiotensin System; Sodium | 2004 |
Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male rats.
Topics: Animals; Biological Transport; Carrier Proteins; Endothelin-1; Heart Failure; Male; Mazindol; Myocardial Contraction; Myocardium; Neurons; Norepinephrine; Perfusion; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar | 2005 |
Effects of endothelin ETA receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure.
Topics: Animals; Blood Pressure; Endothelin A Receptor Antagonists; Heart Failure; Heart Rate; Hypertension; Male; Myocardium; Organ Size; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred SHR; Ventricular Remodeling | 2006 |
Increased cardiac and pulmonary endothelin-1 mRNA expression in canine pacing-induced heart failure.
Topics: Animals; Cardiac Pacing, Artificial; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Gene Expression; Heart Failure; Humans; Lung; Male; Myocardium; Phenylpropionates; Protein Precursors; Pyrimidines; Receptor, Endothelin A; Ribonucleases; RNA, Messenger | 1998 |
Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
Topics: Animals; Blood Pressure; Cardiac Output; Collagen; Coronary Vessels; Dose-Response Relationship, Drug; Echocardiography; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Heart Rate; Hemodynamics; Ligation; Male; Myocardium; Organ Size; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Vasoconstrictor Agents; Ventricular Remodeling; Viper Venoms | 1998 |
Beneficial effects of long-term selective endothelin type A receptor blockade in canine experimental heart failure.
Topics: Administration, Oral; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Dogs; Echocardiography; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Male; Norepinephrine; Phenylpropionates; Pyrimidines; Random Allocation; Receptor, Endothelin A; Vascular Resistance; Ventricular Remodeling | 1998 |
Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators.
Topics: Catecholamines; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Phenylpropionates; Pyrimidines | 2000 |
Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure.
Topics: Acetylcholine; Analysis of Variance; Animals; Aorta; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Heart Failure; In Vitro Techniques; Male; Myocardial Infarction; Nitroprusside; Oxygen; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Renin; Sulfonamides; Superoxide Dismutase; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Role of ET(A) receptors in the regulation of vascular reactivity in rats with congestive heart failure.
Topics: Animals; Cerebral Arteries; Electrocardiography; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Heart Failure; Hemodynamics; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Myocardial Infarction; Nitroarginine; Nitroprusside; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; Vasoconstrictor Agents; Vasodilation; Viper Venoms | 2000 |
Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252.
Topics: Animals; Chronic Disease; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Kidney; Male; Myocardial Infarction; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; Renal Artery; Vasodilation | 2000 |
Effect of ET(A) receptor antagonist on pulmonary hypertension and vascular reactivity in rats with congestive heart failure.
Topics: Animals; Disease Models, Animal; Heart Failure; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Myocardial Infarction; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptors, Endothelin; Vasoconstriction; Vasodilation | 2001 |
Endothelin receptor blockade in congestive heart failure.
Topics: Acute Disease; Antihypertensive Agents; Bosentan; Chronic Disease; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelin-1; Exercise Tolerance; Heart Failure; Hemodynamics; Humans; Phenylpropionates; Pyridines; Pyrimidines; Sulfonamides; Tetrazoles; Treatment Outcome; Vasodilator Agents | 2001 |
Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Collagen; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Heart Failure; Heart Ventricles; Hemodynamics; Indoles; Male; Matrix Metalloproteinase 2; Models, Animal; Myosin Heavy Chains; Norepinephrine; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Renin; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta | 2002 |